JS

Jagpreet Singh

Active Director Director DIN 08272384
DIN 08272384 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Nov 2018
Shareholding value •••• Premium profile

About Jagpreet Singh

Data last updated:

Jagpreet Singh is a Director at Jp Pharma Solutions Private Limited (since 2018) and Director at Bionial Healthcare Private Limited (since 2020). The companies operate in Pharma, Chemicals and Environment. The 2 current companies with reported revenue have a combined latest revenue of ₹111 Cr; the largest is Jp Pharma Solutions Private Limited at ₹86.08 Cr (FY 2024). Earlier, Jagpreet Singh was an Additional Director at Biocuris Pharmaceuticals Private Limited (2024–2026) and Additional Director at Sukh Energy Private Limited (2020–2021) and 2 more.

DIN 08272384
Primary Designation Director
Industry Pharma
First Appointment 01 Nov 2018
Oldest Company Age 8 yrs
Largest company Jp Pharma Solutions Private Limited · ₹86.08 Cr (FY 2024)
Combined revenue ₹111 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jp Pharma Solutions Private Limited U52609PB2018PTC048606
Director01 Nov 20182018₹86.08 Cr (FY 2024)Active
Bionial Healthcare Private Limited U24100PB2020PTC051490
Director25 Jul 20202020₹25.23 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director08 Jun 20242022₹24.4 Lakh (FY 2023)Active
Sukh Energy Private Limited U51900CH2013PTC034746
Additional Director29 Feb 20202013Active
Tagbot Technologies Private Limited U72200CH2019PTC042420
Additional Director05 Mar 20202019Active
Additional Director02 Jun 20202017Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Jagpreet Singh

Directorship timeline

Open interactive timeline →
Bionial Healthcare Private Limited
Jp Pharma Solutions Private Limited
Biocuris Pharmaceuticals Private Limited
Sukh Energy Private Limited
Premium access

Shareholding and investment profile for Jagpreet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagpreet Singh

Jagpreet Singh currently holds 2 directorships: Jp Pharma Solutions Private Limited (Director, since 01 Nov 2018, revenue ₹86.08 Cr (FY 2024)); Bionial Healthcare Private Limited (Director, since 25 Jul 2020, revenue ₹25.23 Cr (FY 2025)).

Jagpreet Singh was first appointed on 01 Nov 2018 as Director at Jp Pharma Solutions Private Limited. The most recent appointment on record is 08 Jun 2024 at Biocuris Pharmaceuticals Private Limited.

The 2 current companies of Jagpreet Singh that report revenue have a combined latest revenue of ₹111 Cr: Jp Pharma Solutions Private Limited ₹86.08 Cr (FY 2024); Bionial Healthcare Private Limited ₹25.23 Cr (FY 2025).

Jagpreet Singh held 4 earlier board appointments: Biocuris Pharmaceuticals Private Limited (Additional Director, 08 Jun 2024 to 15 Jan 2026); Sukh Energy Private Limited (Additional Director, 29 Feb 2020 to 25 Mar 2021); Tagbot Technologies Private Limited (Additional Director, 05 Mar 2020 to 27 Jul 2020); S.O.H Equipments India Private Limited (Additional Director, 02 Jun 2020 to 01 Jan 2021).

The current boards of Jagpreet Singh's companies include Inderpreet Kaur (Jp Pharma Solutions Private Limited), Gulpreet Singh (Bionial Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available